News

Use of insulin detemir in women with pre-existing diabetes who become pregnant appears safe, according to the results of the EVOLVE study.
What is insulin detemir? Response from Zachary T. Bloomgarden, MD Two long-acting insulin analogs have been developed for use as "basal" components of insulin treatment regimens: glargine and detemir.
On average, patients in the detemir group put on less weight than those in the glargine group. However, the differences were small (0.9-1.3 kg).
We have, really, two outstanding insulins for that: insulin glargine, which goes by the trade name Lantus; and insulin detemir, which goes by the trade name Levemir.
Insulin Detemir is a long-acting type of insulin. There are two other long-acting insulins sold under a number of brand names in the U.S.: Insulin Glargine and Insulin Degludec.
It has so far not been proven that the long-acting insulin analogues (LAIAs) insulin detemir (trade name: Levemir) and insulin glargine (trade name: Lantus), which are approved for the treatment ...
Insulin Detemir is a long-acting type of insulin. There are two other long-acting insulins sold under a number of brand names in the U.S.: Insulin Glargine and Insulin Degludec.
Insulin Detemir is a long-acting type of insulin. There are two other long-acting insulins sold under a number of brand names in the U.S.: Insulin Glargine and Insulin Degludec.
Insulin Detemir is a long-acting type of insulin. There are two other long-acting insulins sold under a number of brand names in the U.S.: Insulin Glargine and Insulin Degludec.
Insulin Detemir is a long-acting type of insulin. There are two other long-acting insulins sold under a number of brand names in the U.S.: Insulin Glargine and Insulin Degludec.
Insulin Detemir is a long-acting type of insulin. There are two other long-acting insulins sold under a number of brand names in the U.S.: Insulin Glargine and Insulin Degludec.
Insulin Detemir is a long-acting type of insulin. There are two other long-acting insulins sold under a number of brand names in the U.S.: Insulin Glargine and Insulin Degludec.